Census Bureau. 2004b. The Research Data Center Program. [Online]. Available at: http://184.108.40.206/ces.php/research [accessed July 8, 2004].
Chen RT. 2004. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies. Vaccine 22(15-16):2047-2053.
Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC. 1997. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 99(6):765-773.
California Health Interview Survey (CHIS). 2003. CHIS Research Clearinghouse. [Online]. Available: http://www.chis.ucla.edu/rc/ [accessed November 3, 2004].
CHIS. 2004a. About the California Health Interview Survey. [Online]. Available: http://www.chis.ucla.edu/about.html [accessed June 28, 2004].
CHIS. 2004b. The Data Access Center at the UCLA Center for Health Policy Research. [Online]. Available: http://www.chis.ucla.edu/chis_dac.html [accessed June 28, 2004].
Copeland CW, Simpson M. 2004. The Information Quality Act: OMB’s Guidance and Initial Implementation. [Online]. Available: http://www.ombwatch.org/info/dataquality/RL32532_CRS_DQA.pdf [accessed November 18, 2004].
Council of Public Representatives (COPR) and the National Institutes of Health (NIH). 2004. Enhancing Public Input and Transparency in the National Institutes of Health Reserach Priority-Setting Process. [Online]. Available: http://copr.nih.gov/reports/enhancing.pdf [accessed December 29, 2004].
Cvetkovich G, Siegrist M, Murray R, Tragesser S. 2002. New information and social trust: asymmetry and perseverance of attributions about hazard managers. Risk 22(2): 359-367.
Davis R. 2004 (August 23). Vaccine Safety Datalink: Overview. Presentation to the Committee on Review of NIP’s Research Procedures and Data Sharing Program, Washington, DC.
DeMets D. 2004 (October 21). Interim Analysis of Randomized Clinical Trials. Presentation to the Committee on Review of NIP’s Research Procedures and Data Sharing Program, Washington, DC.
DeStefano F. 2004 (October 21). VSD Studies That Utilized Iterative Analyses. Presentation to the Committee on Review of NIP’s Research Procedures and Data Sharing Program, Washington, DC.
DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT. 2002. Childhood vaccinations and risk of asthma. Pediatr Infect Dis J 21(6):498-504.
Dittmann S. 2001. Vaccine safety: risk communication—a global perspective. Vaccine 19(17-19):2446-2456.
Egan W. 2000. Statement By William Egan, Ph.D., Acting Office Director, Office of Vaccine Research and Review, Center for Biologics Evaluation and Review, Food and Drug Administration, Department of Health and Human Services. Before the Committee on Government Reform: U.S. House of Representatives. [Online]. Available: http://www.fda.gov/ola/2000/vaccines.html [accessed February 7, 2004].
Food and Drug Administration and Center for Biologics Evaluation and Research. 2002. Vaccine Product Approval Process. [Online]. Available: http://www.fda.gov/cber/vaccine/vacappr.htm [accessed February 3, 2005].
Fienberg S. 1994. Sharing statistical data in the biomedical and health sciences: ethical, institutional, legal, and professional dimensions. Annual Review of Public Health 15:1-18.
Fisher BL. 1999. Shots in the Dark: Attempts at Eradicating Infectious Diseases Are Putting our Children at Risk. [Online]. Available: http://www.nextcity.com/contents/summer99/16shots.html [accessed January 13, 2005].